The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $83.10

Today's change-0.21 -0.25%
Updated September 19 4:00 PM EDT. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $83.10

Today's change-0.21 -0.25%
Updated September 19 4:00 PM EDT. Delayed by at least 15 minutes.

Reversal following new 100-day high

CVS Health Corp closed lower Tuesday, dropping (U.S.)$0.21 or 0.25% to (U.S.)$83.10 after setting a new 100-day high. Over the last five days, shares have gained 0.81% and 5.31% year to date. Shares have underperformed the S&P 500 by 23.99% during the last year.

Key company metrics

  • Open(U.S.) $83.75
  • Previous close(U.S.) $83.31
  • High(U.S.) $84.00
  • Low(U.S.) $82.90
  • Bid / Ask(U.S.) $82.86 / (U.S.) $83.39
  • YTD % change+5.31%
  • Volume4,568,000
  • Average volume (10-day)5,371,654
  • Average volume (1-month)5,046,844
  • Average volume (3-month)5,680,154
  • 52-week range(U.S.) $69.30 to (U.S.) $90.85
  • Beta0.92
  • Trailing P/E16.56×
  • P/E 1 year forward14.17×
  • Forward PEG1.76×
  • Indicated annual dividend(U.S.) $2.00
  • Dividend yield2.41%
  • Trailing EPS(U.S.) $5.02
Updated September 19 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.37%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue45,68544,51445,97144,615
Total other revenue--------
Total revenue45,68544,51445,97144,615
Gross profit6,9356,5807,6067,492
Total cost of revenue38,75037,93438,36537,123
Total operating expense43,56842,72142,97641,899
Selling / general / administrative4,8184,7874,6114,675
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0--0101
Other operating expenses, total--------
Operating income2,1171,7932,9952,716
Interest income (expense), net non-operating-251-258-248-258
Gain (loss) on sale of assets--------
Other--------
Income before tax1,8631,5342,7532,463
Income after tax1,0979621,7071,542
Income tax, total7665721,046921
Net income1,0989521,7071,540
Total adjustments to net income-45-9-6
Net income before extra. items1,0979611,7071,541
Minority interest0-10-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,0939661,6981,535
Inc. avail. to common incl. extra. items1,0949571,6981,534
Diluted net income1,0949571,6981,534
Dilution adjustment--------
Diluted weighted average shares1,0241,0351,0701,073
Diluted EPS excluding extraordinary itemsvalue per share1.070.931.591.43
Dividends per sharevalue per share0.500.500.430.43
Diluted normalized EPSvalue per share1.070.931.591.49